You are currently viewing a new version of our website. To view the old version click .

Pharmaceuticals, Volume 11, Issue 2

June 2018 - 30 articles

Cover Story: Over the past few years, drug repositioning has become a relevant strategy for drug discovery, being a time and money saving process. Neurodegenerative diseases are particularly well suited for this approach, as these diseases are age-related and popular treatments of co-morbidities in these kind of pathologies can exhibit beneficial side effects. Our review “Old Drugs as New Treatments for Neurodegenerative Diseases” shows that, in this area of research, the key to the future can be found in the past, and old drugs can become effective new treatments for neurodegenerative diseases. View the paper here.
  • Issues are regarded as officially published after their release is announced to the table of contents alert mailing list .
  • You may sign up for email alerts to receive table of contents of newly released issues.
  • PDF is the official format for papers published in both, html and pdf forms. To view the papers in pdf format, click on the "PDF Full-text" link, and use the free Adobe Reader to open them.

Articles (30)

  • Article
  • Open Access
22 Citations
6,285 Views
14 Pages

Parallel Evolution of Host-Attachment Proteins in Phage PP01 Populations Adapting to Escherichia coli O157:H7

  • Chidiebere Akusobi,
  • Benjamin K. Chan,
  • Elizabeth S.C.P. Williams,
  • John E. Wertz and
  • Paul E. Turner

The emergence of antibiotic resistance has sparked interest in phage therapy, which uses virulent phages as antibacterial agents. Bacteriophage PP01 has been studied for potential bio-control of Escherichia coli O157:H7, its natural host, but in the...

  • Article
  • Open Access
10 Citations
4,944 Views
18 Pages

The 3-trifluoroacetyl–substituted 7-acetamido-2-aryl-5-bromoindoles 5a–h were prepared and evaluated for potential antigrowth effect in vitro against human lung cancer (A549) and cervical cancer (HeLa) cells and for the potential to inhib...

  • Review
  • Open Access
95 Citations
8,213 Views
14 Pages

TRPM Family Channels in Cancer

  • Aline Hantute-Ghesquier,
  • Aurélien Haustrate,
  • Natalia Prevarskaya and
  • V’yacheslav Lehen’kyi

Members of the TRPM (“Melastatin”) family fall into the subclass of the TRP channels having varying permeability to Ca2+ and Mg2+, with three members of the TRPM family being chanzymes, which contain C-terminal enzyme domains. The role of different T...

  • Review
  • Open Access
140 Citations
14,065 Views
21 Pages

Changing Trends in Computational Drug Repositioning

  • Jaswanth K. Yella,
  • Suryanarayana Yaddanapudi,
  • Yunguan Wang and
  • Anil G. Jegga

Efforts to maximize the indications potential and revenue from drugs that are already marketed are largely motivated by what Sir James Black, a Nobel Prize-winning pharmacologist advocated—“The most fruitful basis for the discovery of a n...

  • Review
  • Open Access
230 Citations
24,955 Views
14 Pages

Inflammation and Neuro-Immune Dysregulations in Autism Spectrum Disorders

  • Dario Siniscalco,
  • Stephen Schultz,
  • Anna Lisa Brigida and
  • Nicola Antonucci

Autism Spectrum Disorder (ASD) is characterized by persistent deficits in social communication and interaction and restricted-repetitive patterns of behavior, interests, or activities. Strong inflammation states are associated with ASD. This inflamma...

  • Review
  • Open Access
43 Citations
10,971 Views
48 Pages

Endocannabinoids in Body Weight Control

  • Henrike Horn,
  • Beatrice Böhme,
  • Laura Dietrich and
  • Marco Koch

Maintenance of body weight is fundamental to maintain one’s health and to promote longevity. Nevertheless, it appears that the global obesity epidemic is still constantly increasing. Endocannabinoids (eCBs) are lipid messengers that are involve...

  • Review
  • Open Access
102 Citations
13,927 Views
29 Pages

The current concept in searching for new bioactive products, including mainly original active substances with potential application in pharmacy and medicine, is based on compounds with a previously determined structure, well-known properties, and bio...

  • Feature Paper
  • Article
  • Open Access
19 Citations
8,288 Views
9 Pages

BACKGROUND: Neuropathic pain can be disabling, and is often difficult to treat. Within a year, over half of all patients stop taking their prescribed neuropathic pain medication, which is most probably due to side effects or disappointing analgesic r...

  • Article
  • Open Access
27 Citations
8,585 Views
13 Pages

There are health concerns associated with increased folic acid intake from fortified food and supplements. Existing analytical methods, however, which can be employed to carry out epidemiological and bioavailability studies for folic acid involve lab...

  • Review
  • Open Access
76 Citations
13,506 Views
19 Pages

The paper addresses the safety of febuxostat and summarizes reports on side effects and interactions of febuxostat published by the cut-off date (last day of literature search) of 20 March 2018. Publications on side effects and the interactions of fe...

of 3

Get Alerted

Add your email address to receive forthcoming issues of this journal.

XFacebookLinkedIn
Pharmaceuticals - ISSN 1424-8247